Krystal Biotech Inc (NAS:KRYS)
$ 156.35 -2.65 (-1.67%) Market Cap: 4.47 Bil Enterprise Value: 4.01 Bil PE Ratio: 83.16 PB Ratio: 5.58 GF Score: 38/100

Krystal Biotech Inc Annual Shareholders Meeting Transcript

May 21, 2021 / 08:00PM GMT
Release Date Price: $65.6 (-3.04%)
Operator

Welcome to Krystal Biotech, Inc. Annual Meeting of Stockholders. I would now like to introduce the first presenter, Krish Krishnan, CEO and Chairman of Krystal Biotech, Inc.

Krish S. Krishnan
Krystal Biotech, Inc. - Chairman, President & CEO

Thank you, Tilly. I'm Chris Krishnan, CEO of Krystal Biotech. It's my pleasure to welcome you to our 2021 annual meeting of shareholders. I'm glad you're joining us today, and I sincerely appreciate your continued support of Krystal.

I want to recognize our Board members who may be listening into this meeting: Dan Janney, he's our lead independent Director; Dino Rossi; Julian Gangolli; Kirti Ganorkar and Suma Krishnan.

I also want to welcome our 2 newest directors, Dr. Jing Marantz; and Dr. Chris Mason to Krystal.

The meeting will now come to order.

Our first action in the general order of business will be to review the motions to be considered then we will vote on those motions. After the voting, we will receive a report under voting results, which will then conclude the formal

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot